Exploring the Intersectionality of Race/ethnicity with Rurality on Breast Cancer Outcomes: SEER Analysis, 2000-2016
Overview
Affiliations
Purpose: Disparities in breast cancer survival have been observed within marginalized racial/ethnic groups and within the rural-urban continuum for decades. We examined whether there were differences among the intersectionality of race/ethnicity and rural residence on breast cancer outcomes.
Methods: We performed a retrospective analysis among 739,448 breast cancer patients using Surveillance Epidemiology and End Results (SEER) 18 registries years 2000 through 2016. We conducted multilevel logistic-regression and Cox proportional hazards models to estimate adjusted odds ratios (AORs) and hazard ratios (AHRs), respectively, for breast cancer outcomes including surgical treatment, radiation therapy, chemotherapy, late-stage disease, and risk of breast cancer death. Rural was defined as 2013 Rural-Urban Continuum Codes (RUCC) of 4 or greater.
Results: Compared with non-Hispanic white-urban (NH-white-U) women, NH-black-U, NH-black-rural (R), Hispanic-U, and Hispanic-R women, respectively, were at increased odds of no receipt of surgical treatment (NH-black-U, AOR = 1.98, 95% CI 1.91-2.05; NH-black-R, AOR = 1.72, 95% CI 1.52-1.94; Hispanic-U, AOR = 1.58, 95% CI 1.52-1.65; and Hispanic-R, AOR = 1.40, 95% CI 1.18-1.67), late-stage diagnosis (NH-black-U, AOR = 1.32, 95% CI 1.29-1.34; NH-black-R, AOR = 1.29, 95% CI 1.22-1.36; Hispanic-U, AOR = 1.25, 95% CI 1.23-1.27; and Hispanic-R, AOR = 1.17, 95% CI 1.08-1.27), and increased risks for breast cancer death (NH-black-U, AHR = 1.46, 95% CI 1.43-1.50; NH-black-R, AHR = 1.42, 95% CI 1.32-1.53; and Hispanic-U, AHR = 1.10, 95% CI 1.07-1.13).
Conclusion: Regardless of rurality, NH-black and Hispanic women had significantly increased odds of late-stage diagnosis, no receipt of treatment, and risk of breast cancer death.
Patel P, Sakhi H, Kalvapudi D, Changas A, Sulaimanov M, Gutierrez B J Clin Med Res. 2025; 16(12):608-624.
PMID: 39759488 PMC: 11699865. DOI: 10.14740/jocmr6081.
Disparities in Cancer Stage of Diagnosis by Rurality in California, 2015 to 2019.
Oh D, Wang K, Goldberg D, Schumacher K, Yang J, Lin K Cancer Epidemiol Biomarkers Prev. 2024; 33(11):1523-1531.
PMID: 39141060 PMC: 11530323. DOI: 10.1158/1055-9965.EPI-24-0564.
History of the Surveillance, Epidemiology, and End Results (SEER) Program.
Friedman S, Negoita S J Natl Cancer Inst Monogr. 2024; 2024(65):105-109.
PMID: 39102881 PMC: 11300016. DOI: 10.1093/jncimonographs/lgae033.
Li C, Andrzejak S, Jones S, Williams B, Moore J BMC Womens Health. 2023; 23(1):448.
PMID: 37620873 PMC: 10463695. DOI: 10.1186/s12905-023-02529-3.
Li C, Andrzejak S, Jones S, Williams B, Moore J Res Sq. 2023; .
PMID: 37034626 PMC: 10081371. DOI: 10.21203/rs.3.rs-2644466/v1.